Could a patient’s own stem cells be used to create insulin-secreting cells, even if that patient has type 1 diabetes?
© Elena Pavlovich/Shutterstock.com
T1DM, Pregnancy, and Continuous Glucose Monitoring: Good News
A new open-label randomized controlled trial finds use of CGM in T1DM pregnancies may improve neonatal outcomes.
Impact of Ethnicity, Gender on Skin Autoflourescence and Risk for CV, DM
A new study evaluates the impact of ethnicity on skin autoflourescence used to measure accumulation of atherogenic glycated proteins.
The Revised Cholesterol Guidelines
What about those patients who fall into the "gray zone"?
Low-carbohydrate Diet Controls Glucose Levels in Type 2 Diabetes
The early impact of carbohydrate restriction was clinically significant but not sustained, according to authors of a new meta-analysis.
Early Respiratory Infections and Risk for Type 1 Diabetes: The TEDDY Study
Timing appears to be nearly everything when it comes to the impact of respiratory infection on autoantibody seroconversion in infants at risk for tpye 1 diabetes.
When to Walk Away From an Insurance Company
You can attempt to renegotiate. Sometimes it works . . . but sometimes it doesn’t.
Type 2 Diabetes Patients Show No Increased CV Risk with Once-Weekly Exenatide
The extended-release GLP-1 agonist was added to usual care in T2DM patients with and without previous cardiac disease.
Interesting Endo: AFib, Bone Health, and Obesity
At-a-Glance: Studies you may find of interest look at AFib in T1DM, new fracture risk data, obesity outcomes, and more.
Diabetes Care: How to Close the Gap Between Where We Are and Where We Could Be
Here: 3 strategies that can help fuel the patient's drive to change.
Telemedicine in Type 2 Diabetes Care: Two Stories of Success
A successful lifestyle intervention for advanced diabetes and improved access to diabetic eye care for rural patients showcase telemedicine at its best.